Skip to content
PulseMS
Log inJoin
Research & community

MS research, together.

MS research in plain English. Perspectives from people who understand.

Research evidence filters

Filters apply to reviewed research. Unknown dates and unassessed posts are excluded when a corresponding filter is active.

Reset filters
Topics & sourcesFiltered
Research and community updates, newest first.AI researchClear filters
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyNot reportedTrial registry

Effect of Stimulation Suit on People with MS

A study was planned to evaluate the effectiveness of a full-body stimulation suit on reducing symptoms like spasticity and ataxia in individuals with Multiple Sclerosis (pwMS). Participants were to be divided into an intervention group wearing the suit for 6 weeks and a control group receiving usual care. Clinical tests would be conducted to measure motor function at specific intervals. However, no results from the study have been posted yet.

What this does not proveThe study has not published any results, so its actual outcomes and effectiveness cannot be determined. Details regarding the sample size and overall design are also unclear.
#MSResearch
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyNot reportedTrial registry

Investigation of Skin Tumor Causes in Human Patients with Tuberous Sclerosis

A study is planned to explore the genetic causes of skin tumors in 400 patients diagnosed with tuberous sclerosis, aiming to identify specific tumor cells through genetic analysis.

What this does not proveThe study has not published results, and details like planned enrollment and endpoints are unreported, leaving efficacy and outcomes unknown.
#MSResearch
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedObservationalTrial registry

Genetic Mechanisms of Lung Disease in Unknown Subjects

A study is designed to evaluate the genetic factors related to the development of pulmonary diseases by examining genes that influence respiratory function in lung cells.

What this does not proveThe trial is ongoing with no results posted, so efficacy and results remain undetermined.
#MSResearch
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyInterventionalTrial registry

Study on Combination Drug Therapy in Human MS Patients

Researchers are conducting a trial with 250 MS patients to assess the effect of a combination of drugs on disability progression, measured by the CombiWISE scale, over 1.5 years. The primary endpoint is the change in CombiWISE progression rate compared to baseline.

What this does not proveNo results have been posted yet as the study is ongoing with recruitment still in process and the primary endpoint not reported.
#MSResearch
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyNot reportedTrial registry

Study of Disability Mechanisms in Immune-Mediated CNS Disorders Including Humans

This study is designed to explore how disability develops in people with immune-mediated injuries to the central nervous system (CNS). It involves 2400 subjects, including both patients showing symptoms of CNS damage and healthy volunteers for comparison. Patients may also have follow-up tests with NIH researchers after 1-2 years.

What this does not proveThe study has not posted any results, and its planned enrollment and endpoints do not constitute findings.
#Neuroinflammation
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyPhase 2Trial registry

Safety of Sequential Rituximab and Cladribine Treatment in Relapsing-Remitting MS Patients

The HiHat trial is underway to assess the safety of rituximab followed by cladribine in individuals with relapsing-remitting multiple sclerosis (RRMS). It aims to determine if the rate of serious adverse events (SAEs) is low following this sequential treatment.

What this does not proveResults are not yet available from this Phase 2 trial, and the planned enrollment and endpoints do not constitute findings.
#Other
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyNot reportedTrial registry

Clinical Study on Pulmonary Lymphangioleiomyomatosis (LAM) in Humans

A study has been planned to enroll 2000 individuals with pulmonary lymphangioleiomyomatosis (LAM) to investigate the disease's clinical course and underlying cellular and molecular mechanisms using the Toshiba Aquilion One CT device.

What this does not proveNo results have been reported yet; the planned enrollment and endpoints currently do not provide any findings.
#MSResearch
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyPhase 1Trial registry

Ferumoxytol in Brain MRI for Multiple Sclerosis and Healthy Volunteers

In a Phase 1 pilot study, ferumoxytol was evaluated as a safe contrast agent in brain MRI for healthy volunteers and individuals with multiple sclerosis. The safety was demonstrated by the absence of long-term signal changes, and it was found that ferumoxytol enhancement could be observed in MS lesions using a 7-tesla MRI. However, explicit results have not been reported yet.

What this does not proveThe study has no clear results published; it primarily aimed to assess safety and imaging techniques rather than confirm findings.
#Other
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalTrial registry

Caregiver Observational Study on MS and Related Factors

An observational study is planned to explore the relationships between the severity of multiple sclerosis (MS) and various factors impacting caregivers, such as their sleep quality, physical activity, body awareness, perceived stress, and caregiver burden. The study aims to include 68 caregivers from Başkent University Hospital but has not yet begun recruitment, and no results have been reported.

What this does not proveSince the study has not yet recruited participants or reported any findings, no conclusions can be drawn regarding the associations investigated.
#MSResearch
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPeer-reviewed

Knowledge of Multiple Sclerosis Among Primary Care Physicians in Bahrain

In a survey of 211 primary care physicians in Bahrain, 58.3% recognized multiple sclerosis (MS) as an immune-mediated disorder affecting the central nervous system. The majority identified relapsing-remitting MS as the most common type (60.2%) and preferred MRI for diagnosis (75.8%). Females and younger physicians displayed better knowledge, while only about half knew the relapse criteria and treatment protocol.

What this does not proveThe study reflects knowledge at a single point in time and had a response rate of only 49.3%, which may limit the generalizability of the findings.
#MSResearch
View abstract on PubMedPMID 42844602AI summary of a published abstract. Not medical advice.